MedTrace Logo

Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis

NCT01944150 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2017-08-03

No results posted yet for this study

Summary

At Saint-Antoine's hospital, in CETD a multidisciplinary team takes care of patients with chronic pain. Free-drug techniques are available to reduce their consumption of analgesics. This study is to assess the relief obtained by the simultaneous combination of these two techniques: transcutaneous electrical nerve stimulation and hypnosis.

Conditions

  • Limbs Arthrosis
  • Non Arthrosic Limbs Arthralgia
  • Chronic Lomboradiculalgia
  • Chronic Back Pain
  • Cervical Radiculopathy
  • Post-herpetic Neuralgia
  • Post-surgical Peripheral Neuropathic Pain
  • Post Trauma Neuropathic Pain
  • Complex Regional Pain Syndrome Type I or II
  • Tendinopathy

Interventions

BEHAVIORAL

Transcutaneous electrical nerve stimulation

explanations about devices and their use are given to the patient during the first session. The right place where the electrodes should be placed on, the most effective programme (optimal electric frequency provided by the machine), intensity are tested by the nurse during 30 minutes lasting session

BEHAVIORAL

Transcutaneous electrical nerve stimulation and hypnosis

explanations about devices and their use are given to the patient during the first session. The right place where the electrodes should be placed on, the most effective programme (optimal electric frequency provided by the machine), intensity are tested by the nurse. Following informations are collected by the second nurse: pain representation and its relief thoughts about a quiet place. TENS and hypnosis are associated in a unique 30 minutes session

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Louise GEOFFROY, Nurse · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2017-02-28
Completion
2017-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01944150 on ClinicalTrials.gov